The NC TraCS Institute announced pilot grant awards to researchers focused on COVID-19. In total, 34 applications were received and eight were chosen for funding. Awardees include investigators from UNC’s Eshelman School of Pharmacy, Gillings School of Global Public Health, … Read more
The UNC Catalyst for Rare Diseases hosted a meet-and-greet in the Genetic Medicine Building on Feb. 27 for Rare Diseases Day. Catalyst scientists provided guests an overview of the research group’s mission and rare disease projects. UNC Catalyst is a … Read more
Anthony Hickey, Ph.D., has returned to the UNC Eshelman School of Pharmacy to head up the UNC Catalyst for Rare Diseases. Hickey, a professor in the Division of Pharmacoengineering and Molecular Pharmaceutics from 1993 until 2010, returns to the School … Read more
